NA
AMPH icon

Navellier & Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History

Navellier & Associates’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,591
Closed -$1.52M – 339
2024
Q1 		$1.52M Buy
34,591
+26,864
+348% +$1.39M 0.19% 123
2023
Q4 		$478K Buy
+7,727
New +$406K 0.07% 235
2023
Q1 		– Sell
-13,155
Closed -$369K – 273
2022
Q4 		$369K Sell
13,155
-9,436
-42% -$274K 0.08% 199
2022
Q3 		$635K Sell
22,591
-178
-0.8% -$5.81K 0.14% 141
2022
Q2 		$792K Buy
22,769
+31
+0.1% +$1.11K 0.17% 134
2022
Q1 		$816K Buy
+22,738
New +$645K 0.14% 139

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return